Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

YTEN - Yield10 Bioscience

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Dan Thunderbolt, Apr 19, 2018.

  1. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Bought some shares of YTEN the last couple of days. YTEN is good for a nice run from time to time. The licensing deal with Monsanto gave them tremendous credibility.

    Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean
    Dec 11, 2017
    http://ir.yield10bio.com/news-relea...grants-research-license-monsanto-evaluate-two

    Market Cap of YTEN is currently around $17 million. The company ended 2017 with cash on the balance sheet of $14.5 million. The Company anticipates that its current cash resources will be sufficient to fund operations and meet its obligations for at least the next twelve months. This should be sufficient time to deliver some good news to boost the stock price imo.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    6,225
    Likes Received:
    1,530
    [​IMG]
    Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States. It is developing various yield traits using proprietary advanced biotechnology trait gene discovery platforms. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
     
    OldFart likes this.
  3. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  4. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  5. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  6. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Nice end of day trading action. Keep on radar for possible spike in share price. YTEN makes a run from time to time.
     
  7. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  8. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  9. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Yield10 Bioscience's (YTEN) CEO Oli Peoples on Q1 2018 Results - Earnings Call Transcript
    May.10.18
    https://seekingalpha.com/article/41...ples-q1-2018-results-earnings-call-transcript

    "We ended first quarter of 2018 with $11.6 million in cash, cash equivalents and short-term securities on the balance sheet."

    "We expect our cash on hand together with revenue expected under current government grants to support our operations to a number of technology proof points into mid-2019."

    "Monsanto is the world leader in developing biotech traits in soybean. So it’s great to have them working in C3003 with a unique capabilities and capacity. Our new business model for working with ag major, its also attracted the interest of other parties for both additional gene traits as well as other crops. We have some discussions ongoing and our goal is to work with additional ag companies to bring forward new yield traits."
     
  10. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  11. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    SeeThruEquity Issues Update on Yield10 Bioscience, Inc.

    May 23, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Yield10 Bioscience, Inc. (NASDAQ: YTEN).

    https://www.accesswire.com/500588/SeeThruEquity-Issues-Update-on-Yield10-Bioscience-Inc

    No change to price target at this time ($8.50)
    Our price target for YTEN is unchanged at this time. 1Q18 results set the stage for an important planting season, which should provide additional data for the company's portfolio of traits. We plan to re-evaluate the price target following results, a more expansive update of the Monsanto relationship, or more visibility into the company's other partnership discussions.
     
  12. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    OldFart likes this.
  13. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  14. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  15. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer WOBURN, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced it has signed a non-exclusive research license agreement jointly with the Broad Institute of MIT and Harvard and Pioneer, part of Corteva AgriscienceTM Agriculture Division of DowDuPont (NYSE - DWDP), for the use of CRISPR-Cas9 genome-editing technology for crops. The joint license covers intellectual property consisting of approximately 48 patents and patent applications on CRISPR-Cas9 technology controlled by the Broad Institute and Pioneer. Under the agreement, Yield10 has the option to renew the license on an annual basis and the right to convert the research license to a commercial license in the future, subject to customary conditions as specified in the agreement.

    https://yield10bioscienceinc.gcs-we...nce-signs-research-license-agreement-covering
     
  16. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    I am still very confident that YTEN will make a big run until the end of the year. Cash on hand is sufficient until mid 2019 and they have several upcoming nearterm milestones.

    Q2 2018 Results Earnings Conference Call August 9
    https://seekingalpha.com/article/41...-results-earnings-call-transcript?part=single

    "Yield10 is a strong pipeline of exciting crop trait technologies, which we believe will help us build significant value in the business. We will talk more about our route on C3004 in the next few weeks.

    In 2018, we anticipate reporting our field test results in fourth quarter. Under a research license, Bayer/Monsanto is working the C3003 in soybean, we will update them on C3004 this year.

    We will also continue independent development of C3003 in soybean and rice. We will continue to progress oil-enhancing traits using CRISPR genome editing, a progress of C4000 series traits in rice and corn in the months ahead."
     
  17. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina
    --Fast-Tracking Deployment of C3004 Trait into Canola and Soybean

    WOBURN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced promising results for its novel yield trait C3004 in growth chamber studies conducted using its Camelina platform. Camelina plant lines containing C3004 grew vigorously, and the best lines produced increases in seed yield in a range of 26% to 65% as compared to control plants. Yield10 plans to conduct field tests of the C3004 trait in Camelina as part of its 2019 Field Test program in Canada. In addition, Yield10 is fast tracking deployment of the C3004 trait into canola and soybean to determine if the trait produces similar effects on plant vigor and seed yield in major oilseed crops.

    “Our early research results with C3004 in Camelina including plant growth and vigor, branching and seed yield, though preliminary, are very encouraging,” said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “These initial seed yield data for C3004 suggest we can harness the metabolic machinery of plants to drive robust increases in seed yield in Camelina. The next step is to determine if the effects of C3004 on plant vigor and seed yield can be successfully achieved in Camelina under field conditions and translated into canola, soybean and other commercial crops.”

    https://globenewswire.com/news-rele...04-in-Growth-Chamber-Studies-in-Camelina.html
     
  18. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
    Sep 21, 2018


    Yield10 Bioscience Grants Research License to Forage Genetics to Evaluate Novel Yield Traits in Sorghum

    WOBURN, Mass., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today announced that it has granted a non-exclusive research license to Forage Genetics International, LLC, a subsidiary of Land O’Lakes, Inc., to evaluate five novel yield traits in forage sorghum. Under the license, Forage Genetics plans to conduct research with the novel traits within its sorghum development program as a strategy to improve biomass yields.
    http://ir.yield10bio.com/news-relea...ience-grants-research-license-forage-genetics
     
  19. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2
  20. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    149
    Likes Received:
    2

Share This Page